Repligen Corp. (RGEN)
113.43
+1.69
(+1.51%)
USD |
NASDAQ |
May 21, 16:00
113.43
0.00 (0.00%)
After-Hours: 19:59
Repligen Research and Development Expense (TTM) : 54.79M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| West Pharmaceutical Services, Inc. | 73.80M |
| Reflect Scientific, Inc. | 0.0237M |
| Quantum-Si, Inc. | 54.53M |
| BioLife Solutions, Inc. | 23.53M |
| Baxter International, Inc. | 489.00M |